Epidemiology of Hepatitis Virus B and C

Dehesa-Violante, Margarita; Núñez-Nateras, Rafael

doi:10.1016/j.arcmed.2007.03.001

Cited by 57 publications

(39 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These causes can vary between them by geographic area. (Dehesa-Violante M, 2007;Fattovich G, 2008) These conclusions coincide in this series, since the average age was 47.8 ± 12.95 years. The group more frequent were in patients between 40 to 60 years, male sex and the most frequent causes of cirrhosis were HCV and alcohol.…”

Section: Discussionsupporting

confidence: 85%

Prognostic Factors for Survival in Patients with Liver Cirrhosis

Samada¹,

Hernández²

2012

Liver Transplantation - Basic Issues

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 85%

Prognostic Factors for Survival in Patients with Liver Cirrhosis

Samada¹,

Hernández²

2012

Liver Transplantation - Basic Issues

View full text Add to dashboard Cite

“…The prevalence in blood donors is 0.69% in Paraguay, 0.66% in Mexico, 0.65% in Argentina, 0.57% in Peru, 0.56% in Bolivia and 0.9% in Chile [39]. In Brazil, found prevalence among blood donors from the Federal District of 0.2%.…”

Section: Epidemiologymentioning

confidence: 91%

Hepatitis C: Viral Features and Clinical Aspects

Da-Silva¹,

Zanella²

2016

J Prev Inf Cntrl

View full text Add to dashboard Cite

Knowledge on hepatitis caused by hepatitis C virus (HCV) has increased since 1989, when the virus was identified and cloned from the complementary deoxyribonucleic acid (DNA) extracted from cells of an experimentally infected chimpanzee with the virus of hepatitis non-A, non-B. Approximately 90% of cases of post-transfusion hepatitis and 50% to 70% of sporadic cases of hepatitis non-A and non-B were caused by HCV. Thus, the discovery of this virus has enabled the development of serological diagnosis techniques. In recent years, there have been major advances in the characterization of the molecular structure of HCV, the development of diagnostic tests with high specificity and sensitivity, knowledge about the pathogenic mechanisms and improved therapeutic options. The continued study of this disease allowed the characterization of its epidemiology and main routes of transmission. Currently, HCV competes with alcoholic liver disease as the leading cause of chronic liver disease. As shown asymptomatic in most cases, this disease progresses silently for chronicity with a consequent increase in cases of liver cirrhosis and hepatocellular carcinoma (HCC). This study reviews the main aspects of the hepatitis C. HCV infection is progressive, silent and causes the patient serious complications such as cirrhosis and HCC, and brings high costs to the government. Therefore, given the diversity of problems caused by epidemic HCV, this study is essential to new discoveries about this health problem.

show abstract

“…Over 15 million people are infected with hepatitis D virus (HDV) (Farci et al, 2006;Dehesa et al, 2007). In the Middle East, HBV infection shows an intermediate rate, varying between 2 and 7% in different countries (Qirbi et al, 2001).…”

Section: Introductionmentioning

confidence: 99%